Literature DB >> 6498672

The "new" ampicillins: who needs them? Committee on Infectious Diseases and Immunization, Canadian Paediatric Society.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6498672      PMCID： PMC1483677     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Double-blind clinical trials of oral cyclacillin and ampicillin.

Authors:  J A Gold; C P Hegarty; M W Deitch; B R Walker
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

2.  Comparative evaluation of the aminopenicillins for oral use.

Authors:  G H McCracken
Journal:  Pediatr Infect Dis       Date:  1983 Jul-Aug

3.  Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children.

Authors:  C M Ginsburg; G H McCracken; M L Thomas; J Clahsen
Journal:  Pediatrics       Date:  1979-11       Impact factor: 7.124

4.  Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin.

Authors:  J Sjövall; L Magni; T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

5.  Comparative pharmacokinetics of cyclacillin and amoxicillin in infants and children.

Authors:  C M Ginsburg; G H McCracken; T C Zweighaft; J C Clahsen
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.